Nanalysis Announces Second Quarter 2025 Results
Nanalysis Scientific Corp. (OTCQX: NSCIF) reported challenging Q2 2025 results marked by a 17% decline in total revenue to $9.6 million. Product sales dropped significantly by 46% to $2.9 million, while security services revenue increased by 7% to $5.6 million.
Despite revenue challenges, the company achieved notable improvements in product sales gross margins, increasing to 61% from 50% year-over-year. The company reported an Adjusted EBITDA loss of $462,000 compared to a profit of $759,000 in Q2 2024, and a net loss of $2.1 million.
Key developments include closing a $2 million promissory note financing, implementing efficiency measures in security services, and securing loan amendments to reduce principal payments through April 2026.
Nanalysis Scientific Corp. (OTCQX: NSCIF) ha comunicato risultati difficili per il secondo trimestre 2025, con un calo del 17% dei ricavi totali a 9,6 milioni di dollari. Le vendite di prodotti sono diminuite in modo marcato, del 46% a 2,9 milioni, mentre i ricavi dai servizi di sicurezza sono aumentati del 7% a 5,6 milioni.
Nonostante la flessione dei ricavi, l'azienda ha migliorato significativamente i margini lordi sulle vendite di prodotti, saliti al 61% dal 50% rispetto a un anno prima. Ha riportato un Adjusted EBITDA negativo di 462.000 dollari rispetto a un utile di 759.000 dollari nel Q2 2024 e una perdita netta di 2,1 milioni.
Tra gli sviluppi principali figurano la chiusura di un finanziamento tramite cambiale da 2 milioni di dollari, l'attuazione di misure di efficienza nei servizi di sicurezza e la concessione di emendamenti ai prestiti per ridurre i pagamenti del capitale fino ad aprile 2026.
Nanalysis Scientific Corp. (OTCQX: NSCIF) present贸 unos resultados complicados en el segundo trimestre de 2025, con una ca铆da del 17% en los ingresos totales hasta 9,6 millones de d贸lares. Las ventas de productos se redujeron considerablemente, un 46% hasta 2,9 millones, mientras que los ingresos por servicios de seguridad aumentaron un 7% hasta 5,6 millones.
A pesar de los retos en los ingresos, la compa帽铆a mejor贸 de forma notable los m谩rgenes brutos de las ventas de productos, que subieron al 61% desde el 50% interanual. Registr贸 un EBITDA ajustado negativo de 462.000 d贸lares frente a un beneficio de 759.000 d贸lares en el Q2 de 2024 y una p茅rdida neta de 2,1 millones.
Entre los hitos clave est谩n el cierre de un financiamiento mediante pagar茅 de 2 millones de d贸lares, la implementaci贸n de medidas de eficiencia en los servicios de seguridad y la obtenci贸n de enmiendas a pr茅stamos para reducir los pagos del capital hasta abril de 2026.
Nanalysis Scientific Corp. (OTCQX: NSCIF)電� 2025雲� 2攵勱赴鞐� 鞏措牑鞖� 鞁れ爜鞚� 氚滍憸頄堨溂氅�, 齑濍Г於滌澊 17% 臧愳唽頃� 960毵� 雼煬毳� 旮半頄堨姷雼堧嫟. 鞝滍拡 韺愲Г電�
毵れ稖 鞎呿檾鞐愲弰 攵堦惮頃橁碃 鞝滍拡 毵れ稖 齑濍歆勳潃 鞝勲厔 雽牍� 50%鞐愳劀 61%搿� 雽韽� 臧滌劆霅橃棃鞀惦媹雼�. 須岇偓電� 臁办爼 EBITDA 靻愳嫟 46毵�2觳� 雼煬毳� 旮半頄堨溂氅�, 鞚措姅 2024雲� 2攵勱赴鞚� 75毵�9觳� 雼煬 鞚挫澋瓿� 牍勱祼霅╇媹雼�. 靾滌啇鞁れ潃 210毵� 雼煬鞓赌鞀惦媹雼�.
欤检殧 靷暛鞙茧電� 200毵� 雼煬 鞎届啀鞏挫潓(頂勲氙胳劀毽吀韸�) 鞛愱笀 臁半嫭 毵堦皭, 氤挫晥 靹滊箘鞀れ潣 須湪靹� 鞝滉碃 臁办箻 鞁滍枆, 攴鸽Μ瓿� 2026雲� 4鞗旉箤歆 鞗愱笀 靸來櫂鞚� 欷勳澊旮� 鞙勴暅 雽於� 靾橃爼 瓿勳暯 觳搓舶 霌膘澊 鞛堨姷雼堧嫟.
Nanalysis Scientific Corp. (OTCQX: NSCIF) a publi茅 des r茅sultats difficiles pour le 2e trimestre 2025, avec une baisse de 17% du chiffre d'affaires total 脿 9,6 millions de dollars. Les ventes de produits ont chut茅 de mani猫re significative, de 46% 脿 2,9 millions, tandis que les revenus des services de s茅curit茅 ont augment茅 de 7% 脿 5,6 millions.
Malgr茅 la pression sur les revenus, la soci茅t茅 a nettement am茅lior茅 les marges brutes sur les ventes de produits, qui sont pass茅es 脿 61% contre 50% sur un an. Elle a enregistr茅 une perte d'EBITDA ajust茅 de 462 000 dollars contre un b茅n茅fice de 759 000 dollars au T2 2024, et une perte nette de 2,1 millions.
Parmi les faits marquants figurent la cl么ture d'un financement par billet 脿 ordre de 2 millions de dollars, la mise en place de mesures d'efficacit茅 pour les services de s茅curit茅 et des avenants de pr锚t visant 脿 r茅duire les remboursements du capital jusqu'en avril 2026.
Nanalysis Scientific Corp. (OTCQX: NSCIF) meldete herausfordernde Ergebnisse f眉r das zweite Quartal 2025: Die Gesamtums盲tze fielen um 17% auf 9,6 Mio. USD. Der Produktabsatz ging deutlich um 46% auf 2,9 Mio. USD zur眉ck, w盲hrend die Erl枚se aus Sicherheitsdienstleistungen um 7% auf 5,6 Mio. USD stiegen.
Trotz r眉ckl盲ufiger Ums盲tze verbesserte das Unternehmen die Bruttomargen im Produktbereich deutlich auf 61% statt 50% im Jahresvergleich. Es wies ein bereinigtes EBITDA-Verlust von 462.000 USD aus gegen眉ber einem Gewinn von 759.000 USD im Q2 2024 und einen Nettoverlust von 2,1 Mio. USD.
Wesentliche Entwicklungen sind der Abschluss einer 2-Millionen-Dollar-Schuldverschreibung, Effizienzma脽nahmen im Bereich Sicherheitsdienstleistungen und Kredit盲nderungen zur Reduzierung der Tilgungszahlungen bis April 2026.
- Product sales gross margin improved significantly to 61% from 50% year-over-year
- Security services revenue grew 7% to $5.6 million
- Successfully secured $2 million in financing through promissory notes
- Obtained favorable loan amendments reducing principal payments and extending amortization to 2028
- Total revenue declined 17% to $9.6 million year-over-year
- Product sales dropped severely by 46% to $2.9 million
- Adjusted EBITDA turned negative at -$462,000 versus +$759,000 in Q2 2024
- Net loss increased to $2.1 million from $2.0 million year-over-year
"The first half of 2025 has been challenging because of economic uncertainty caused by global tariff and trade conditions. The second quarter reflected lower product sales, which had a direct impact on our financial results," said Sean Krakiwsky, Founder and CEO of Nanalysis. "Even so, our cost reduction and efficiency measures have continued to support stronger margins in the scientific equipment business. In our security services segment, the team's focus on scheduling, logistics, and cost management has led to sequential margin improvement, and we expect these efforts will continue to benefit margins in the coming quarters.
"Our plan remains unchanged, we are focused on building a vertically integrated scientific instrumentation company, advancing our Benchtop NMR platforms, and strengthening our service business. Operational execution and efficiency will remain at the core of how we deliver results as we progress on the path to long-term profitable growth."
Financial highlights for the three months ended听June 30, 2025:
Three months ended June 30 | |||||
( | 2025 | 2024 | Change $ | Change % | |
Product sales | 2,902 | 5,402 | (2,500) | -46听% | |
Security services revenue | 5,617 | 5,265 | 352 | 7听% | |
Flow-through inventory revenue | 1,057 | 807 | 250 | 31听% | |
Total sales and revenue | 9,576 | 11,474 | (1,898) | -17听% | |
Gross margin percentage - product sales | 61听% | 50听% | 11听% | ||
Gross margin percentage - service revenue | 10听% | 10听% | 0听% | ||
Adjusted EBITDA | (462) | 759 | (1,221) | ||
Normalized net loss (excludes impairment of assets) | (2,122) | (1,795) | (327) | -18听% | |
Net loss | (2,122) | (1,995) | (127) | -6听% |
- For the three months ended June 30, 2025, the Company reported consolidated revenue of
, a decrease of$9,576 or$1,898 17% from the comparative period in 2024. This decline was primarily driven by lower product sales, as ongoing global economic uncertainty and tariff risks continued to constrain customer capital budgets. Within the security services segment, revenue increased modestly by7% year-over-year. - Gross margin percentage for the three-month period ended June 30, 2025, on product sales was
61% , versus50% for the three-month period ended June 30, 2024. Continuous improvement efforts have resulted in significantly improved margins over the prior year. - Security service gross margin percentage in the quarter was
10% , the same as in the prior year comparative period. The Company has initiated improvements in its processes to better manage cost of security services, including better scheduling, improving logistics processes and managing overtime and on-call hours. This has resulted in an improvement in margins of4% over Q1 2025, and the Company expects to continue seeing margins improve for the remainder of the year. - Adjusted EBITDA (loss) for the three months ended June 30, 2025, was (
) versus an Adjusted EBITDA profit of$462 in the same period last year. This was primarily the result of a drop in scientific equipment sales in the quarter.$759 - Net loss was
for the second quarter of 2025, which is$2,122 higher than the same period in 2024. The increase in net loss was due to lower revenues from scientific equipment sales offset by lower depreciation, stock-based compensation, and the fact that losses from associate are no longer recorded in the consolidated statement of loss and comprehensive loss due to the impairment of the Quad investment in 2024.$127
Financial highlights for the six months ended听June 30, 2025:
Six months ended June 30 | |||||
( | 2025 | 2024 | Change $ | Change % | |
Product sales | 6,589 | 9,618 | (3,029) | -31听% | |
Security services revenue | 10,640 | 9,988 | 652 | 7听% | |
Flow-through inventory revenue | 2,941 | 3,030 | (89) | -3听% | |
Total sales and revenue | 20,170 | 22,636 | (2,466) | -11听% | |
Gross margin percentage - product sales | 64听% | 49听% | 15听% | ||
Gross margin percentage - service revenue | 8听% | 9听% | -1听% | ||
Adjusted EBITDA | (282) | 655 | (937) | ||
Normalized net loss (excludes impairment of assets) | (3,429) | (4,317) | 888 | 21听% | |
Net loss | (3,429) | (4,517) | 1,088 | 24听% |
- The Company reported consolidated revenue of听
$20,170 , a decrease of ,466听辞谤$2 11% from the comparative period in 2024. This is primarily the result of a decrease in product sales, offset by a$3,029 increase in security services revenue.$652 - Gross margin percentage on product sales was
64% for the six months ended听June 30, 2025, up from49% in the prior year. Continuous improvement programs continue to support improvements in 2025 gross margins. - Gross margin percentage on service revenue was
8% for the six months ended听June 30, 2025, compared to9% in 2024. The Company has reversed its margin decline from Q4 2024 and Q1 2025 and looks to continue growing margins for the rest of 2025. - Adjusted EBITDA loss for the six months ended听June 30, 2025, was听(
$282) 听versus Adjusted EBITDA$655 听for the same period last year. The drop was primarily due to a decrease in product sales.$3,029
Quarterly Trend:
( | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
Product sales | 2,902 | 3,687 | 5,536 | 4,242 |
Security services revenue | 5,617 | 5,023 | 5,602 | 5,420 |
Flow-through parts revenue | 1,057 | 1,884 | 1,151 | 908 |
Total revenue | 9,576 | 10,594 | 12,289 | 10,570 |
Adjusted EBITDA | (462) | 180 | 1,904 | 545 |
Normalized net loss | (2,122) | (1,307) | (400) | (1,570) |
- In Q2 2025, product sales were down by
from Q1 2025 mainly due to full quarter impacts of economic uncertainty and tariff risks. This has cooled markets for capital equipment globally and eliminated expected 2025 growth and, in fact, resulted in a decline in overall sales globally. This was offset by an increase in security service revenue of$785 due to increased labour hours as well as the realization of certain contractual service bonuses.$594
Recent strategic and operational highlights during and after the second quarter of 2025 include:
- Margin Improvement in Security Services: Process and logistics improvements initiated in Q2 led to better scheduling and cost control in the Airport Security Maintenance Business, resulting in sequential gross margin improvement from Q1. This is expected to continue through the remainder of 2025, as our new EVP of Services begins to have an impact on improved operations.
- Closed Promissory Note Financing: On June 12, 2025, the Company closed a fully subscribed private placement of unsecured promissory notes for gross proceeds of
. The notes bear$2,000 12% annual interest, payable in cash or, in common shares of the Company. In connection with the financing, the Company issued 1,600,000 common shares at per share to the lenders, representing$0.25 20% of the principal amount. Net proceeds will be used for general working capital purposes and to support ongoing operations. - Signed an amending agreement with its lender: During the period ending June 30, 2025, the Company signed an amending agreement with its lender, obtaining a reduction in its loan principal payment from May 31, 2025, to April 30, 2026, as well as an extension of its loan amortization to May 31, 2028.
Outlook
"As we move into the second half of 2025, we continue to see a solid sales funnel; however, the first half highlighted how tariff risks and broader economic conditions can influence the timing of capital equipment purchases," said Mr. Krakiwsky.
"In the Security Services segment, the team has been implementing efficiency measures introduced in the second quarter, with a focus on scheduling, logistics, and cost management. These efforts, together with ongoing cost control and working capital discipline, are directed at improving operational effectiveness.
"Across both product and services, our focus remains on efficiency, margin improvement, and the continued advancement of our Benchtop NMR platforms and service offerings. The team is committed to process improvements and execution, as we persevere through these difficult economic conditions" added Mr. Krakiwsky.
Conference Call:
Investors interested in participating in the live full year call can dial 437-900-0527 or 1-888-510-2154 from听abroad. Investors can also access the call online through a listen-only webcast here 听or on the investor relations section of the Company's website .
The webcast will be archived on the Company's investor relations webpage for at least 90 days, and a telephonic playback will be available for seven days after the conference call by calling 1-888-660-6345 or 289-819-1450, conference ID #83432.
Additionally, the Company will be hosting a Q&A session for its European investors at 8:30am ET tomorrow, Friday, August 听29th, which can be accessed by the following link: .
Non-IFRS and Supplementary Financial Measures
The Company prepares and reports its consolidated financial statements in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board, 鈥巃s adopted 鈥巄y the Canadian Accounting Standards Board ("IFRS"). However, this press release may make reference to certain non-IFRS measures including key 鈥巔erformance indicators used by management. These measures are not recognized measures under IFRS 鈥巃nd do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable 鈥巘o similar measures presented by other companies. Rather, these measures are provided as additional 鈥巌nformation to complement those IFRS measures by providing further understanding of the Company's results of 鈥巓perations from management's perspective. Accordingly, these measures should not be considered in 鈥巌solation nor as a substitute for analysis of the Company's financial information reported under IFRS.
The 鈥嶤ompany uses Flow-through parts revenue, Security services revenue, Adjusted Earnings Before Interest, Tax, Depreciation and Amortization ("Adjusted EBITDA"), and Normalized net loss as non-IFRS measures, which may be calculated 鈥巇ifferently by other companies. These non-IFRS measure are used to provide investors supplemental measures of the Company's operating performance and liquidity and thus highlight trends in the Company's 鈥巄usiness that may not otherwise be apparent when relying solely on IFRS measures. The Company also 鈥巄elieves that securities analysts, investors and other interested parties frequently use non-IFRS measures 鈥巌n the evaluation of companies in similar industries.
Flow through parts revenue and Security services revenue
听Three months ended June 30听 | ||||
( | 2025 | 2024 | 听($) Change听 | |
Security services revenue | 5,617 | 5,265 | 352 | |
Flow-through inventory revenue | 1,057 | 807 | 250 | |
Total Service Revenue | 6,674 | 6,072 | 602 | |
Security services costs | 5,065 | 4,759 | 306 | |
Flow-through inventory costs | 1,057 | 807 | 250 | |
Total Cost of Services | 6,122 | 5,566 | 556 | |
听Six months ended June 30听 | ||||
( | 2025 | 2024 | 听($) Change听 | |
Security services revenue | 10,640 | 9,988 | 652 | |
Flow-through inventory revenue | 2,941 | 3,030 | (89) | |
Total Service Revenue | 13,581 | 13,018 | 563 | |
Security services costs | 9,789 | 9,114 | 675 | |
Flow-through inventory costs | 2,941 | 3,030 | (89) | |
Total Cost of Services | 12,730 | 12,144 | 586 |
Adjusted EBITDA
听Three months ended June 30听 | ||||
( | 2025 | 2024 | 听($) Change听 | |
Net loss | (2,122) | (1,995) | (127) | |
Depreciation and amortization expense | 1,051 | 1,154 | (103) | |
Finance expense | 359 | 357 | 2 | |
Stock-based compensation | 112 | 388 | (276) | |
Other (income) expenses | (44) | 350 | (394) | |
Amortization of deferred wages | 216 | 276 | (60) | |
Loss from associate | - | 235 | (235) | |
Current income tax expense | 10 | 2 | 8 | |
Deferred income tax recovery | (44) | (8) | (36) | |
Adjusted EBITDA | (462) | 759 | (1,221) | |
听Six months ended June 30听 | ||||
( | 2025 | 2024 | 听($) Change听 | |
Net loss | (3,429) | (4,517) | 1,088 | |
Depreciation and amortization expense | 1,975 | 2,306 | (331) | |
Finance expense听 | 686 | 711 | (25) | |
Stock-based compensation | 243 | 648 | (405) | |
Other (income) expenses | (182) | 604 | (786) | |
Amortization of deferred wages | 406 | 466 | (60) | |
Loss from associate | - | 435 | (435) | |
Current income tax expense听 | 37 | 34 | 3 | |
Deferred income tax recovery | (18) | (32) | 14 | |
Adjusted EBITDA | (282) | 655 | (937) |
Adjusted EBITDA by Quarter
( | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
Net loss | (2,122) | (1,307) | (7,452) | (1,644) |
Depreciation and amortization expense | 1,051 | 924 | 1,155 | 1,165 |
Finance expense | 359 | 327 | 293 | 341 |
Stock-based compensation | 112 | 131 | 199 | 181 |
Other (income) expenses | (44) | (138) | 124 | (94) |
Amortization of deferred wages | 216 | 190 | 215 | 214 |
Loss from associate | - | - | 345 | 305 |
Impairment of assets | - | - | 7,052 | 74 |
Current income tax expense (recovery) | 10 | 27 | 33 | (22) |
Deferred income tax (recovery) expense | (44) | 26 | (60) | 25 |
Adjusted EBITDA | (462) | 180 | 1,904 | 545 |
Normalized net loss
( | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
Net loss | (2,122) | (1,307) | (7,452) | (1,644) |
Impairment of assets | - | - | 7,052 | 74 |
Normalized net loss | (2,122) | (1,307) | (400) | (1,570) |
Supplementary Financial Measures听
The Company may also use supplementary financial measures which are intended to be disclosed on a periodic basis to depict the historical or expected future financial performance, cash position, or cash flow of the Company, are not a non-IFRS measure, and are not presented in the financial statements. The measures as discussed in this press release include:
- Gross margin percentage, which is defined as either (Product sales less Cost of product sold) divided by Product sales or (Security services revenue less Security services costs) divided by Security services revenue
About 听(TSXV: NSCI, OTCQX: NSCIF, FRA:1N1)
Nanalysis Scientific Corp. is a scientific instrumentation company with proprietary products and services groups working synergistically. The Company is a leading developer and supplier of cryogen-free portable Nuclear Magnetic Resonance (NMR) spectrometers, with a family of proprietary products that sell around the world in the pharma, biotech, energy, food, chemical, advanced materials, and security verticals, as well as in universities and government labs. Whether it is a new drug being developed, a lithium brine pool sample, polymer analysis, or assessing adulteration in foods, customers use the company's products to identify molecular structure. The Company's products are patent protected and manufactured in-house to protect intellectual property and optimize quality and costs. The Company leverages its technology by selling hardware and software on an original equipment manufacturer (OEM) basis to medical imaging customers. The Company provides services to its customers on its proprietary products, as well as on third-party imaging equipment, such as x-ray scanners in airports, border crossings, consulates, and correctional facilities. In 2022, the company won a
Notice regarding Forward Looking Statements and Legal Disclaimer
This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
View original content to download multimedia:
SOURCE Nanalysis Scientific Corp.